| Literature DB >> 30186970 |
Aura Silva1, Pedro Amorim2, Luiza Felix3, Fernando Abelha4, Joana Mourão4.
Abstract
BACKGROUND: Patients with intellectual disability (ID) often require general anesthesia during oral procedures. Anesthetic depth monitoring in these patients can be difficult due to their already altered mental state prior to anesthesia. In this study, the utility of electroencephalographic indexes to reflect anesthetic depth was evaluated in pediatric patients with ID.Entities:
Keywords: Bispectral Index; Electroencephalogram; General Anesthesia; Intellectual Disability
Year: 2018 PMID: 30186970 PMCID: PMC6115373 DOI: 10.17245/jdapm.2018.18.4.235
Source DB: PubMed Journal: J Dent Anesth Pain Med ISSN: 2383-9309
Characteristics of the patients included in this study (N=17). Demographic data, anesthetic procedure data, and underlying neurological disorders in patients studied, as well as the patients' medication, are presented.
| Age (years) | 9.6 ± 2.9 |
| Female/male | 7 / 10 |
| Weight (kg) | 43.4 ± 17.3 |
| Body mass index (kg/m2) | 19.0 ± 2.5 |
| Duration of anesthesia (min) | 85.8 ± 41.9 |
| Duration of surgery (min) | 67.6 ± 36.1 |
| Recovery of the mental state prior to anesthesia (min) | 12.5 ± 7.0 |
| Drugs used to induce anesthesia (propofol sevoflurane) | 4 / 13 |
| Received rocuronium | 16 |
| Neostigmine/Sugammadex | 11 / 5 |
| Underlying neurological disorders of the patients | Autism spectrum disorder (n = 3); Anoxic encephalopathy and/or cerebral palsy (n = 4); Metabolic disease (n = 2); Hyperactivity syndrome and attention deficit ( n = 1 ); Fetal-alcohol fetal spectrum disorder (n = 1); Down's syndrome (n = 1); Fragile X syndrome (+ epilepsy) (n = 1); West syndrome (+ epilepsy) (n = 1); Menkes syndrome (n = 1); Unknown cause of intellectual disability (n = 2) |
| Medications taken by the patients | Valdispert (n = 1); Anticonvulsants (n = 6); Risperidal (n = 2); Benzodiazepines (n = 5); Baclofen (n = 2); No medication (n = 6) Unknown medication (n = 2) |
Fig. 1Box and Wiskers representing the minimum, maximum, and median values of the Spearman correlation coefficients obtained between the end-tidal sevoflurane (EtSevo) and the indexes studied (on the left) as well as the prediction probability values (Pk) on the right. The results are shown for the bispectral index (BIS), spectral edge frequency 95% (SEF95 - %) and total power (TP -uV). *represents significant differences at P < 0.05 level between the group with high and those with low correlation between the indexes and EtSevo and the clinical scale of anesthesia.
Correlation coefficients (Spearman Rank R – R value) and Precition probabilities (Pk) for the bispectral index (BIS), spectral edge frequency (SEF95), and total power (TP).
| BIS | SEF95 | TP | ||||
|---|---|---|---|---|---|---|
| R | Pk | R | Pk | R | Pk | |
| High correl | 0.71 | 1 | 0.69 | 1 | 0.68 | 1 |
| 0.84 | 0.99 | 0.81 | 0.38 | 0.52 | 0.76 | |
| 0.84 | 0.71 | 0.7 | 0.92 | 0.86 | 0.67 | |
| 0.76 | 0.74 | 0.75 | 0.77 | 0.58 | 0.77 | |
| 0.84 | 0.88 | 0.77 | 0.76 | 0.87 | 0.91 | |
| 0.77 | 0.78 | 0.47 | 0.69 | 0.7 | 0.77 | |
| 0.6 | 0.78 | 0.57 | 0.78 | 0 | 0.76 | |
| 0.8 | 0.82 | 0.84 | 0.82 | 0.82 | 0.78 | |
| 0.51 | 0.78 | 0.89 | 0.83 | 0.59 | 0 | |
| 0.64 | - | 0.84 | - | 0.62 | 0.73 | |
| 0.65 | 0.76 | 0.68 | 0.43 | 0.61 | 0.77 | |
| 0.79 | 0.96 | 0.75 | 1 | 0.71 | 1 | |
| Low correl | 0.62 | 0.64 | 0.59 | 0.57 | 0 | 0.58 |
| 0.4 | 0.54 | 0.48 | 0.52 | 0.67 | 0.67 | |
| 0.31 | 0.41 | 0.56 | 0.41 | 0.29 | 0.66 | |
| 0.71 | 0.62 | 0.64 | 0.57 | 0 | 0 | |
Missing values are shown with a “-”: This was due to a low number of clinical observations of clinical depth of anesthesia, making it impossible to perform the Pk calculation for these moments.
Description of the anesthesia periods selected for analysis and mean values of the studied indexes at each moment in the group of patients who had high correlation with the end-tidal sevoflurane concentration and high prediction probabilities (“High correlation group”) and in the group of patients who had low correlation with the end-tidal sevoflurane concentration and high prediction probabilities (“Low correlation group”).
| Awake | N | After induction | N | Surgery | N | Recovery | N | ||
|---|---|---|---|---|---|---|---|---|---|
| EtSevo (%) | High correlation group | 0.0 ± 0.0 | 13 | 4.8 ± 1.2* | 8 | 2.5 ± 0.8* | 12 | 0.05 ± 0.08* | 10 |
| Low correlation group | 0.0 ± 0.0 | 4 | 5.4 ± 1.8 | 2 | 2.5 ± 0.7 | 4 | 0.0 ± 0.0 | 2 | |
| BIS | High correlation group | 80 | 1 | 33 ± 14.8 | 13 | 35.4 ± 6.0 | 12 | 76.4 ± 6.9* | 10 |
| Low correlation group | 77.9 ± 27.3 | 4 | 49.8 ± 13.3 | 3 | 44.3 ± 17.0 | 4 | 77.8 ± 1.5 | 2 | |
| SEF95 (%) | High correlation group | 18.9 | 1 | 9.0 ± 4.5 | 13 | 11.7 ± 1.7 | 12 | 20.3 ± 4.8* | 10 |
| Low correlation group | 10.0 ± 5.0 | 2 | 13.8 ± 2.4 | 3 | 12.4 ± 3.3 | 4 | 15.9 | 1 | |
| TP (uV) | High correlation group | 65.6 | 1 | 78.2 ± 5.5 | 13 | 77.0 ± 2.7 | 12 | 67.9 ± 3.4* | 10 |
| Low correlation group | 74.5 ± 7.3 | 2 | 72.0 ± 6.7 | 3 | 70.5 ± 5.7 | 4 | 71.0 | 1 | |
| ASYM | High correlation group | 51.4 | 1 | 52.1 ± 4.5 | 13 | 50.5 ± 3.6 | 12 | 50.0 ± 3.2 | 10 |
| Low correlation group | 44.8 ± 30.4 | 2 | 56.7 ± 1.8 | 3 | 55.3 ± 3.1 | 4 | 52.9 | 1 | |
After induction – in the moment of highest anesthetic depth after induction of anesthesia
Recovery – when the patient recovered the mental state prior to anesthesia
EtSevo-%: End-tidal sevoflurane concentration; BIS: bispectral index; SEF95: spectral edge frequency 95%; TP: total power; Mean and standard deviation are shown. ASYM: Asymmetry indicator. The number of subjects (N) at each study period are shown.
*Statistically significant P-value at the 0.05 level in comparison to the previous time period; ¥ Statistically significant P-value at the 0.05 level when comparing indexes values recorded from the left and right